Further studies revealed that microglia-specific knockout of Calhm2 also improved pathological manifestations in AD mice, and both in vivo and in vitro experiments demonstrated that inhibition of Calhm2 significantly inhibited microglial activation 24. Here, CALHM2 is linked to Alzheimer disease.